Viewing Study NCT04200066


Ignite Creation Date: 2025-12-24 @ 4:16 PM
Ignite Modification Date: 2026-02-02 @ 1:20 PM
Study NCT ID: NCT04200066
Status: WITHDRAWN
Last Update Posted: 2022-08-22
First Post: 2019-12-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma
Sponsor: University of Rochester
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioblastoma View
None Brain Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Maprotiline View
None Tamoxifen View
None Temozolomide View